AGP Executive Report
Last update: 11 hours agoMedicinal & public health: A CDC-linked report says marijuana shows up in 21% of unintentional overdose deaths, rising to 43% for ages 12–17, with researchers pointing to an early-intervention opportunity to prevent cannabis use disorder. Market snapshot (US): Connecticut adult-use cannabis sales total $713M since the 2023 launch, with flower still the top seller and average flower price down to $6.61/gram in August. Policy & enforcement (global): Nigeria’s NDLEA ex-official Sule Momodu warns decriminalising cannabis could fuel crime and mental health harm, citing strong THC in the Nigerian variety. Law & order (cannabis in court): A Co Down man admitted breaking into a neighbour’s flat and setting it on fire, with prosecutors saying he also had herbal cannabis and other drugs. Medicinal cannabis business (ASX): Vitura Health is in a “reset” after price compression pushed it to a net loss, while ECS Botanics and Little Green Pharma both face ongoing pressure from sector-wide price compression despite business updates. Industry quality claims: The Hemp Doctor says an independent medically reviewed LeafReport scored its CBD edibles highly for price and lab accuracy.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
